Pulmonális artériás hipertónia: vizsgálatok itt: Hollandia
11 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 16.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in HollandiaA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Amsterdam, Nieuwegein
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-513613-12-00 - No phaseTaking peopleTrial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Where
- Rotterdam, Utrecht
- Életkor
- 18 év and over
- People
- 850 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT06526195 - 2. fázisTaking peopleStudy to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Where
- Groningen
- Életkor
- 1 év to 17 év
- People
- 42 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT05587712 · EU 2023-504861-22-00 - 4. fázisNot yet taking people in HollandiaInitial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
- Where
- Amsterdam
- Életkor
- 18 év to 75 év
- People
- 110 worldwide
- Run by
- AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06317805 · EU 2023-504351-26-01 - 3. fázisBefejeződöttOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Amsterdam, Rotterdam
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - 3. fázisFut, nem toborozA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - 1. fázisNot yet taking people in HollandiaTargeting fibrotic tissue with a radioactive-labelled Fibrobody, visible using a full-body PET/CT scan (FibroVision)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 57
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-521143-20-00 - 3. fázisTaking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Amsterdam
- Életkor
- 18 év to 75 év
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - 4. fázisTaking peopleRight Ventricular Compensation With Sotatercept: A Prospective Single Arm Open Label Phase 4 Study to Evaluate the Effects of Sotatercept on Right Ventricular Function in Pulmonary Arterial Hypertension (RECOMPENSE)
- Where
- Amsterdam
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06658522 · EU 2024-512543-23-00 - No phaseTaking peopleCardiopulmonary Toxicity of Thoracic Radiotherapy
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT03978377 - No phaseTaking peopleBPA in CTEPD Without PH
- Where
- Amsterdam
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT06090838